Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity

Africa disproportionately bears the brunt of the global disease burden. It has the highest prevalence of infectious diseases and some of them are unique to the continent, such as tsetse-transmitted trypanosomosis. Consequently, it is imperative for Africa to find therapies to such diseases. In spite...

Full description

Saved in:
Bibliographic Details
Main Authors: Chigorimbo-Murefu, Nyaradzo T. L., Mugumbate, Grace, Chibale, Kelly
Format: Book chapter
Language:English
Published: John Wiley & Sons, Ltd 2022
Subjects:
Online Access:https://doi.org/10.1002/9781118460566.ch4
http://hdl.handle.net/11408/4893
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1779905300229259264
author Chigorimbo-Murefu, Nyaradzo T. L.
Mugumbate, Grace
Chibale, Kelly
author_facet Chigorimbo-Murefu, Nyaradzo T. L.
Mugumbate, Grace
Chibale, Kelly
author_sort Chigorimbo-Murefu, Nyaradzo T. L.
collection DSpace
description Africa disproportionately bears the brunt of the global disease burden. It has the highest prevalence of infectious diseases and some of them are unique to the continent, such as tsetse-transmitted trypanosomosis. Consequently, it is imperative for Africa to find therapies to such diseases. In spite of the intellectual and scientific capacity on the continent, as well as the rich natural resources it possesses, Africa is yet to supply a drug on the market. This chapter discusses some of the platforms that will enable Africa to effectively participate in the discovery of new drug entities. The application of these technologies to natural products is explored in detail and their relevance to Africa highlighted.
format Book chapter
id ir-11408-4893
institution My University
language English
publishDate 2022
publisher John Wiley & Sons, Ltd
record_format dspace
spelling ir-11408-48932022-06-28T07:39:58Z Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity Chigorimbo-Murefu, Nyaradzo T. L. Mugumbate, Grace Chibale, Kelly Natural Product-Based Drug Discovery Drug discovery Africa African biodiversity Africa disproportionately bears the brunt of the global disease burden. It has the highest prevalence of infectious diseases and some of them are unique to the continent, such as tsetse-transmitted trypanosomosis. Consequently, it is imperative for Africa to find therapies to such diseases. In spite of the intellectual and scientific capacity on the continent, as well as the rich natural resources it possesses, Africa is yet to supply a drug on the market. This chapter discusses some of the platforms that will enable Africa to effectively participate in the discovery of new drug entities. The application of these technologies to natural products is explored in detail and their relevance to Africa highlighted. 2022-06-28T07:39:58Z 2022-06-28T07:39:58Z 2014 Book chapter 9781118460610 9781118460566 DOI:10.1002/9781118460566 https://doi.org/10.1002/9781118460566.ch4 http://hdl.handle.net/11408/4893 en Novel Plant Bioresources: Applications in Food, Medicine and Cosmetics;Chapter 4, pages 57-67 open John Wiley & Sons, Ltd
spellingShingle Natural Product-Based Drug Discovery
Drug discovery
Africa
African biodiversity
Chigorimbo-Murefu, Nyaradzo T. L.
Mugumbate, Grace
Chibale, Kelly
Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity
title Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity
title_full Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity
title_fullStr Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity
title_full_unstemmed Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity
title_short Enabling Technologies to Facilitate Natural Product-Based Drug Discovery from African Biodiversity
title_sort enabling technologies to facilitate natural product-based drug discovery from african biodiversity
topic Natural Product-Based Drug Discovery
Drug discovery
Africa
African biodiversity
url https://doi.org/10.1002/9781118460566.ch4
http://hdl.handle.net/11408/4893
work_keys_str_mv AT chigorimbomurefunyaradzotl enablingtechnologiestofacilitatenaturalproductbaseddrugdiscoveryfromafricanbiodiversity
AT mugumbategrace enablingtechnologiestofacilitatenaturalproductbaseddrugdiscoveryfromafricanbiodiversity
AT chibalekelly enablingtechnologiestofacilitatenaturalproductbaseddrugdiscoveryfromafricanbiodiversity